The Annual Meeting of Stockholders of Varian Medical Systems, Inc. (the "Company") was held on February 14, 2013 (the "Stockholders' Meeting"). The Company's stockholders voted on the following four proposals at the Stockholders' Meeting and cast their votes as follows:

Proposal One:



The following individuals were elected to serve as directors for three-year
terms ending with the 2016 Annual Meeting of Stockholders by the votes set forth
in the following table:



                      For     Withheld  Broker Non-Votes
R. Andrew Eckert   80,056,366 1,779,287    9,754,412
Mark R. Laret      81,251,387  584,266     9,754,412

Directors Susan L. Bostrom, Timothy E. Guertin, David J. Illingworth, Richard M. Levy, Ruediger Naumann-Etienne, Venkatraman Thyagarajan and Dow R. Wilson continued in office following the Stockholders' Meeting.

Proposal Two:

The stockholders approved, on an advisory (non-binding) basis, the compensation of the Company's named executive officers, by the votes set forth in the following table:

For Against Abstain Broker Non-Votes 76,430,427 2,693,458 2,711,768 9,754,412

Proposal Three:

The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for fiscal year 2013 was ratified, by the votes set forth in the following table:

For Against Abstain Broker Non-Votes(1) 90,444,443 1,018,903 126,719 --

Proposal Four:

The stockholders approved a stockholder proposal urging the Board of Directors to take all necessary steps to eliminate the classification of the Board of Directors.

For Against Abstain Broker Non-Votes 61,251,632 20,395,992 188,029 9,754,412

(1) Pursuant to the rules of the New York Stock Exchange, this proposal constituted a routine matter. Therefore, brokers were permitted to vote without receipt of instructions from beneficial owners.